{"id":"W2979830663","doi":"10.1182/blood.v116.21.862.862","title":"Carfilzomib, Lenalidomide, and Dexamethasone In Newly Diagnosed Multiple Myeloma: Initial Results of Phase I/II MMRC Trial","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Carfilzomib; Lenalidomide; Neutropenia; Medicine; Dexamethasone; Multiple myeloma; Toxicity; Refractory (planetary science); Internal medicine; Phases of clinical research; Pharmacology; Urology; Gastroenterology; Materials science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00305074,0.001309012,0.00262245,0.0002979761,0.0004023918,0.001174829,0.0008703554,0.001195895,0.002353687],"category_scores_gemma":[0.001252766,0.0004295247,0.001183495,0.0005213818,0.0005608856,0.0007101474,0.0004232236,0.002662432,0.0007035167],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001386543,"about_ca_system_score_gemma":0.00145752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001728525,"about_ca_topic_score_gemma":0.004683421,"domain_scores_codex":[0.9992239,0.000409141,0.00004429502,0.0001072792,0.00009283338,0.0001224896],"domain_scores_gemma":[0.9989979,0.0001684474,0.0001901894,0.00008325973,0.00006455004,0.0004957474],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7880793,0.02989239,0.01896866,0.001450262,0.003395041,0.000639062,0.000379364,0.002432044,0.02233312,0.0002350507,0.00955231,0.1226434],"study_design_scores_gemma":[0.7959839,0.1460089,0.04446987,0.0001212376,0.001672704,0.0008148655,0.00006512311,0.001029685,0.002147204,0.0001559941,0.007493312,0.00003720823],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9704199,0.01755169,0.0005451191,0.001492057,0.0001689634,0.003238874,0.002680847,0.0001706652,0.003731871],"genre_scores_gemma":[0.9772676,0.007330974,0.001814454,0.001694244,0.0003916645,0.002659691,0.006027624,0.00004960264,0.002764159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00305074,"threshold_uncertainty_score":0.01613408,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0364600752379513,"score_gpt":0.3428658753765564,"score_spread":0.3064058001386051,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}